Hospital for Special Surgery Contemporary Topics in Vasculitis 2024

Name: Hospital for Special Surgery Contemporary Topics in Vasculitis 2024
SKU: 9678
Availability: InStock
Rating: 5.00 (2 reviews)

Rated 5.00 out of 5 based on 2 customer ratings

(2 customer reviews)

$89.99

Frequently Bought Together!
Save money buying these products together

Hospital for Special Surgery Contemporary Topics in Vasculitis 2024

This item: Hospital for Special Surgery Contemporary Topics in Vasculitis 2024

$89.99

Harvard Update in Clinical Cardiology 2024 Videos + Slides

1 × Harvard Update in Clinical Cardiology 2024 Videos + Slides

Guaranteed Safe Checkout

24/7 support available
Payments are encrypted and 100% secure

Categories: Cardiology, Courses Tags: cardiology, Hospital for Special Surgery Contemporary Topics in Vasculitis 2024 Product ID: 9678

Description
Reviews (2)

Description

11 videos, size: 4.23 GB

Join our distinguished panel of national experts and key thought leaders who will provide comprehensive insights into the latest advances in the diagnosis and treatment of systemic vasculitis. Participants will learn about updates in systemic vasculitis from disease pathogenesis to diagnostic approaches to novel therapeutics. Interactive sessions will offer opportunities to discuss challenging vasculitis cases with the experts and peers.

Hospital for Special Surgery designates this live activity. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives | HSS continuing medical education activities are intended to improve the quality of patient care and safety. After the course, the participant should be able to:

Discuss the role of biologic therapy in the management of giant cell arteritis and polymyalgia rheumatica and understand the emerging role of large vessel imaging in these diseases.
Define the key immunologic mechanisms in Behcet’s Disease and recognize how these mechanisms drive disease phenotypes and therapeutic options.
Identify the evolving treatment landscape in the ANCA-associated vasculitides and discuss data behind strategies aiming to limit corticosteroid exposure in the management of granulomatosis with polyangiitis, microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis.

+ Topics:

Session 1 Polymyalgia Rheumatica Giant Cell Arteritis GCA – Imaging.mp4
Session 1 Polymyalgia Rheumatica Giant Cell Arteritis Great Debate (PMR GCA) – Upfront Use of IL-6 Inhibitors.mp4
Session 1 Polymyalgia Rheumatica Giant Cell Arteritis Therapy of GCA and PMR in 2024.mp4
Session 2 Vasculitis Mimics and Behcet’s Disease Behcet’s Disease.mp4
Session 2 Vasculitis Mimics and Behcet’s Disease Vasculitis Mimics.mp4
Session 3 ANCA Vasculitis ANCA Vasculitis Update on Management.mp4
Session 3 ANCA Vasculitis Eosinophilic Granulomatosis with Polyangiitis.mp4
Session 3 ANCA Vasculitis Limited GPA.mp4
Session 4 Difficult Cases Case 1 Overlap ANCA IgG4-RD.mp4
Session 4 Difficult Cases Case 2 GCA and Bilateral Optic Perineuritis.mp4
Session 5 Perspectives and Unmet Needs in Vasculitis Bringing Clinical Trial Data to the Bedside.mp4